recent study shared by the U.S. Centers for Disease Control and Prevention. The study, which was published in JAMA on Sept. 2, observed blood donations between July 2020 and May 2021 and studied 1,443,519 blood specimens.
Between July 202 and December 2020, antibodies created in blood donors who were infected by the novel coronavirus increased from 3.5% to 11.5%.
Once the U.S. Food and Drug Administration authorized emergency use of COVID-19 vaccines and official vaccination rollouts began in December for the greater population, antibodies in blood donors increased 83.3%, the study said. RELATED: C.1.2 variant: New coronavirus strain has highest mutation rate yet, study says The study also found that infection-induced antibodies were more.